about
Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.Multi-factorial modulation of colorectal carcinoma cells motility - partial coordination by the tetraspanin Co-029/tspan8Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.Mitochondrial roles and cytoprotection in chronic liver injuryClinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.New perspectives and strategy research biomarkers for hepatocellular carcinoma.Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma.Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma.Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma.Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians.MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung.Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer.Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.Rapid automated simultaneous screening of (G1691A) Factor V, (G20210A) prothrombin, and (C677T) methylenetetrahydrofolate reductase variants by multiplex PCR using fluorescence scanning technology.Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers.The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.Prospective evaluation of blood concentration of mitochondrial DNA as a marker of toxicity in 157 consecutively recruited untreated or HAART-treated HIV-positive patients.Protective effect against alcohol dependence of the thermolabile variant of MTHFR.Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping?Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability.[Breast metastases from lung cancers with the EGFR mutation].Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis.[Molecular biology and hepatocellular carcinoma: current status and future prospects]High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.GENE-06. CO-OCCURRENCE OF DOUBLE MUTATION H3F3A/BRAF IN PEDIATRIC GANGLIOGLIOMAS.Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial.Historadiological correlations in high-grade glioma with the histone 3.3 G34R mutation.Plasma levels of soluble Fc gamma receptors II (sCD32) and III (sCD16) in patients with heparin-induced thrombocytopeniaAssociation between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholismRole of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies[Antiplatelet glycoprotein monoclonal antibodies: properties and practical value]Real-time quantitation of bcr-abl transcripts in haematological malignanciesTests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeReal-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinomaDetection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplantsMicrosatellite instability in European hepatocellular carcinomaAcquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis
P50
Q33502063-44F066AA-DD31-41EE-B874-C642B96240B6Q33689085-91417B9D-04DB-40CD-AB9F-D9F246922E1AQ34130409-1633694C-DB56-4CB3-BF49-38E73438B2F8Q36055801-EBB82415-7625-4283-89EE-BE2D46A51412Q36618179-D019CC17-AAB2-485D-B2A4-3A21F278BE4AQ36883798-D95DABF3-A564-48E2-8B35-7C07702FBF9EQ39094276-EC817691-C492-4BAB-A504-3C91EB996A1FQ39475786-CCC39F52-8002-4B15-90D9-68270E70D086Q40213703-5A41FACA-424E-421F-9674-167003BBBC03Q40313664-AC87CE6D-1B33-49F6-9914-8A85588B9FE1Q41612456-AA0B2983-3566-4B5E-B861-40FC237C04C0Q42133269-F1DC9E08-B8A3-41B6-B301-EA710524EFE4Q42278045-74672A63-68E3-4FAB-8042-BDD701C90126Q43253684-0C8889B5-B9BA-4C70-A99E-CABC281502DAQ43777395-7138F807-0B7F-4093-8D20-67C49631CAD2Q44254571-7D9D2B51-B5A9-492B-B05B-329902494E8EQ44680926-D98BDFDC-C060-4B37-BD43-C5D2AA59269BQ44807344-218416C1-6E92-4D4C-99E2-B0EFB3E890EEQ44879927-2BAD81C3-BB57-4AA7-A73A-902D780EF641Q46712102-1A56C0A5-9FC7-4ACE-8CAE-666B44CBE842Q51033072-FFA4A75B-6628-4960-A40A-B8798F030D89Q51099990-90F0EF06-564C-4459-BAAB-31F01A6AE341Q52599881-E0D3BCF5-964D-47F9-9C41-12F893AE45F8Q53086296-0F43493D-5560-4A8E-9D5E-84558AF2A2B5Q53551074-9DA50076-F50E-471F-B5C0-813F93104B92Q53816195-D3A252DB-2C13-4AE8-91FF-772303FF4241Q53843394-24C11710-9D91-48E9-AE92-B76A7D6821D4Q54854730-5B3809CC-64D5-4FBF-95E3-2EA2664F0BB4Q55057369-C0E024D6-B7FB-487E-8D6F-274DD1388957Q55457489-D6650088-A140-480C-B0A0-176227F0B9A9Q56966655-7BEB2640-9D66-4B00-8693-94CBA6BDD5ABQ62132632-7CAF6CBD-3CD2-4FD8-AD8C-342BDE3DE2A0Q71441073-5746D921-6E44-4003-B68F-DAB885998443Q71777509-413FDC9B-E089-401B-BA4C-D4810070C2DDQ73176504-E057E505-AD47-4A2C-9F13-CDFA2B8E90ACQ73497750-91789A4A-5E3D-44BE-B6FE-655AD9789AEEQ73741058-0A867B2A-7E2C-4BE3-85DA-C2711F088BA1Q74420414-FB489B1B-3F48-43E5-9311-C884E6B61D33Q77931531-4E179EF5-5F93-4BEE-A8A7-A11BE62E1630Q83978360-25D22AAD-380A-4884-B1F8-F9A735885175
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-9878-3669
@en
name
Raphael Saffroy
@ast
Raphael Saffroy
@en
Raphael Saffroy
@es
Raphael Saffroy
@nl
type
label
Raphael Saffroy
@ast
Raphael Saffroy
@en
Raphael Saffroy
@es
Raphael Saffroy
@nl
prefLabel
Raphael Saffroy
@ast
Raphael Saffroy
@en
Raphael Saffroy
@es
Raphael Saffroy
@nl
P106
P21
P31
P496
0000-0002-9878-3669